BMA board of science in discussion about long COVID

Add to calendar
Online
View on map

This event will cover the lived experience of long COVID and its assessment and treatment. Join us to hear about the current research and the next steps that can be taken to improve patient care and outcomes.

Calendar article illustration
Register now

This event is free for all doctors.

What to expect

The panel will discuss:

  • what long COVID is and the actions that can be taken to build on the research, assessment, and treatment of the condition
  • how the prevention and treatment of long COVID should be the Government’s scientific and public health priority
  • the lived experience of long COVID.

 

What you will learn

  • Hear about how long COVID is defined and the impact on patients' lives.
  • Get updated about the current research on long COVID from various experts.
  • Learn about how long COVID is assessed and treated.

The BMA will be applying for CPD accreditation for this online event.

 

Speakers and talks

The event will be chaired by Professor Dame Parveen Kumar and Dr David Strain.

 

Current research on long COVID

Professor Dame Parveen Kumar - BMA board of science

Parveen chairs the BMA board of science and is an emerita professor of medicine and education at Barts and the London School of Medicine, Queen Mary University of London.

She is also a non-executive director for St Georges Hospital NHS Foundation Trust, on the access review committee for the 100.000 genome project and is ambassador to UK Health Alliance for Climate Change.

She is a past president of the BMA, RSM, RMBF and Women’s Medical Federation. She was the vice president of the RCP, chaired the Medicines Commission UK, and was a founding NED for NICE.

What is COVID and long COVID - the lived experience

Dr David Strain - BMA medical academic staff committee

Dr David Strain is a senior clinical lecturer at the University of Exeter Medical School, an honorary consultant in medicine for the older adult, head of the academic department for healthcare for older adults and part of the British Medical Association’s board of science, UK council and medical academic staff committee.

Clinically, he runs a community diabetes service for the older adult, works as an in-patient stroke consultant, and participates in the chronic fatigue service.

In a pre-COVID world his main research focus is the health of older adults with diabetes; ensuring the right patient gets the right treatment. This included leading the consensus statement that led to modification of NICE guidance, and a change in QOF framework for the management of older adults with diabetes and frailty.

He is the clinical lead of the Diabetes and Vascular Research Centre where much of the world-leading expertise in microvascular disease is based. As part of his work there he was establishing a research program exploring underlying causes of chronic fatigue syndrome.

Since March 2020, he has been heavily involved in the COVID-19 response team. Within the BMA, he has been part of the academic response to the pandemic, including leading the team that produced the first risk assessment tool for healthcare workers. He has also contributed to several briefing statements such as the position statement on face masks, easing of lockdowns and long COVID. He represents the BMA of the NHS long COVID task force, as part of the service delivery and research subgroups.

Clinically throughout the pandemic, he has become the clinical lead for COVID services at the Royal Devon & Exeter NHS Foundation Trust, whilst running a COVID ward, contributing to the COVID community virtual ward and helped develop one of the long COVID assessment services in the south west.

Dr Amy Small - locum GP in East Lothian

Amy is a locum GP in Lothian. She was a partner for 10 years but lost her job after becoming ill with long COVID and has been striving to support patients with this illness since it arose.

Aside from her clinical work she works with Chest, Heart, Stroke Scotland who provide support for patients with long COVID.

She sits on a Scottish Government group who are looking at patient pathways for people with long COVID in Scotland.

Amy also is an elected member of the BMA's Scottish council and UK GP committee.

Research on long COVID in the Longitudinal Health and Wellbeing National Core Study

Professor Jonathan Sterne - Bristol Medical School

Jonathan Sterne is professor of medical statistics and epidemiology at the University of Bristol and director of the Health Data Research UK South-West Better Care Partnership.

He is co-lead of the Longitudinal Health and Wellbeing COVID-19 National Core Study. This aims to understand the health, social and economic impacts of the COVID-19 pandemic by uniting established population cohorts and national anonymised electronic health records to inform policy.

An international research leader in medical statistics and epidemiology, he led development of tools to assess the risk of bias in randomised trials and non-randomised studies that are used by systematic review authors worldwide.

Since 2005, he has led the ART Cohort Collaboration of European and North American HIV cohort studies. This has made substantial contributions to understanding the prognosis and treatment of people living with HIV in the era of combination antiretroviral therapy.

Attributes and predictors of long COVID and insights post-vaccination

Dr Claire Steves - Kings College London

Claire is a clinical senior lecturer at King’s College London who designed the clinical content for the COVID Symptom Study App together with ZOE Global.

She is research lead for the app as well as a practicing consultant geriatrician at Guys and St Thomas’s NHS Foundation Trust and the deputy director (clinical) for TwinsUK.

Her work with the app has highlighted older people’s experience, both in terms of severity and duration of disease, and in relation to changes in lifestyle after lockdown.

Before COVID, Claire undertook research into the interactions between physical and mental health in ageing, particularly in relation to the body’s microbiome.

Claire graduated first class from Cambridge University in 1997, gained her medical degree from Bart and the London School of Medicine and Dentistry in 2000 and worked as a hospital doctor for many years before obtaining a research PhD 2014.

She lives in South London with her husband and three children.

Long COVID post-hospitalisation - the PHOSP-COVID experience

Professor Chris Brightling - University of Leicester

Chris Brightling is a fellow of the Academy of Medical Sciences, National Institute for Health Research senior investigator, respiratory theme lead for Leicester NIHR Biomedical Research Centre, director institute for Lung Health and honorary consultant respiratory physician in Leicester.

He is coordinator for the European Union Consortium AirPROM, MRC/ABPI COPD (COPDMAP) Consortium, the MRC Molecular Pathology Node EMBER and respiratory lead for the IMI 3TR.

He was founding director of the European Respiratory Society Clinical Research Collaborations and is the current ERS science council chair.

He is the national lead for the post-COVID consortium PHOSP-COVID and local research lead for the COVID-19 pandemic.

His main research focus is on improving the clinical management and understanding the immunopathogenesis of the airway diseases asthma, chronic cough and COPD.

He is a member of the American College of Chest Physicians’ Cough Guidelines, the British Thoracic Society, American Thoracic Society/European Respiratory Society Severe Asthma guidelines and is on the scientific committee for the Global INitiative for Asthma - GINA.

Rehabilitation for long COVID

Professor Sally Singh - University of Leicester

Sally Singh is professor of pulmonary and cardiac rehabilitation at the University of Leicester. She is also head of pulmonary and cardiac rehabilitation at the University Hospitals of Leicester NHS Trust and director of the Centre for Exercise and Rehabilitation Science, a multidisciplinary group of researchers conducting a range of research projects in the field of exercise and rehabilitation.

She is PI for an NIHR Global Research Group exploring culturally appropriate rehabilitation in low and middle income countries.

She is the clinical lead for pulmonary rehabilitation as part of National Asthma and COPD Audit Programme (NACAP) and is the lead clinician for the Pulmonary Rehabilitation Service Accreditation Scheme run by the RCP.

She co-chaired the American Thoracic Society /European Respiratory Society guidance on rehabilitation in the hospital and post-hospital phase from a European in the post COVID population.

Programme

This session will be held online. 

Attendees will have the opportunity to submit questions for the speakers both before and during the event. 

Who can attend

This event is free for BMA members and non-members.

Registration is free but you need to book your place to be able to attend.